Analysts maintain bullish outlook on Mycronic following earnings beat

Investment banks DNB, Carnegie, and SHB have issued positive ratings for Mycronic after the company exceeded earnings estimates and raised its full-year guidance. The consensus attributes the growth to sustained AI-driven demand, though the sustainability of this sector-specific momentum remains subject to broader market volatility.